CMLT
CM Life Sciences III Inc. Class A Common Stock
stock NASDAQ

eqrx is committed to making innovative medicines at dramatically lower prices for the benefit of people and society. by bringing together stakeholders from across the healthcare system and utilizing the latest advances in science and technology, the company seeks to discover, develop and deliver high-quality, patent-protected medicines more efficiently and cost-effectively than ever before. headquartered in cambridge, massachusetts, the company is backed by gv, arch venture partners, andreessen horowitz, casdin capital, section 32, nextech, and arboretum ventures.